BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25687365)

  • 1. Advanced heart failure due to cancer therapy.
    Shah S; Nohria A
    Curr Cardiol Rep; 2015; 17(4):16. PubMed ID: 25687365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart Failure Therapies for End-Stage Chemotherapy-Induced Cardiomyopathy.
    Mukku RB; Fonarow GC; Watson KE; Ajijola OA; Depasquale EC; Nsair A; Baas AS; Deng MC; Yang EH
    J Card Fail; 2016 Jun; 22(6):439-48. PubMed ID: 27109619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced heart failure therapies for patients with chemotherapy-induced cardiomyopathy.
    Oliveira GH; Qattan MY; Al-Kindi S; Park SJ
    Circ Heart Fail; 2014 Nov; 7(6):1050-8. PubMed ID: 25415958
    [No Abstract]   [Full Text] [Related]  

  • 4. Advanced Heart Failure Therapies for Cancer Therapeutics-Related Cardiac Dysfunction.
    Bianco CM; Al-Kindi SG; Oliveira GH
    Heart Fail Clin; 2017 Apr; 13(2):327-336. PubMed ID: 28279418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management.
    Steingart RM; Yadav N; Manrique C; Carver JR; Liu J
    Semin Oncol; 2013 Dec; 40(6):690-708. PubMed ID: 24331191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracycline-related cardiotoxicity in childhood cancer survivors.
    Lipshultz SE; Karnik R; Sambatakos P; Franco VI; Ross SW; Miller TL
    Curr Opin Cardiol; 2014 Jan; 29(1):103-12. PubMed ID: 24284979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced cardiomyopathy.
    Higgins AY; O'Halloran TD; Chang JD
    Heart Fail Rev; 2015 Nov; 20(6):721-30. PubMed ID: 26338137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Heart Failure in Cancer Patients and Cancer Survivors.
    Finet JE
    Heart Fail Clin; 2017 Apr; 13(2):253-288. PubMed ID: 28279414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: outcomes from the INTERMACS Registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Oliveira GH; Dupont M; Naftel D; Myers SL; Yuan Y; Tang WH; Gonzalez-Stawinski G; Young JB; Taylor DO; Starling RC
    J Am Coll Cardiol; 2014 Jan; 63(3):240-8. PubMed ID: 24161324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac or cardiopulmonary transplantation in childhood cancer survivors: an increasing need?
    Levitt G; Anazodo A; Burch M; Bunch K
    Eur J Cancer; 2009 Nov; 45(17):3027-34. PubMed ID: 19744853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Ventricular Dysfunction and Chemotherapeutic Agents.
    Clasen SC; Wald JW
    Curr Cardiol Rep; 2018 Mar; 20(4):20. PubMed ID: 29520629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardio-oncology: cardiovascular complications of cancer therapy.
    Henning RJ; Harbison RD
    Future Cardiol; 2017 Jul; 13(4):379-396. PubMed ID: 28660778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac pathology in patients after therapy for Hodgkin's lymphoma].
    Danilenko AA; Shakhtarina SV
    Vopr Onkol; 2011; 57(1):119-25. PubMed ID: 21598720
    [No Abstract]   [Full Text] [Related]  

  • 14. Right ventricular function in long-term adult survivors of childhood lymphoma and acute lymphoblastic leukaemia.
    Christiansen JR; Massey R; Dalen H; Kanellopoulos A; Hamre H; Ruud E; Kiserud CE; Fosså SD; Aakhus S
    Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):735-41. PubMed ID: 26917232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure and chemotherapeutic agents.
    Piper S; McDonagh T
    Future Cardiol; 2015 Jul; 11(4):453-70. PubMed ID: 26234158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular complications of cancers and anti-cancer therapy].
    Vyskočil J; Petráková K; Jelínek P; Furdek M
    Vnitr Lek; 2017; 63(3):200-209. PubMed ID: 28379023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer.
    Ylänen K; Poutanen T; Savikurki-Heikkilä P; Rinta-Kiikka I; Eerola A; Vettenranta K
    J Am Coll Cardiol; 2013 Apr; 61(14):1539-47. PubMed ID: 23500246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular toxicities of cancer chemotherapy.
    Bonita R; Pradhan R
    Semin Oncol; 2013 Apr; 40(2):156-67. PubMed ID: 23540741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardioprotective treatment during adjuvant cancer therapy].
    Gulati G; Heck SL; Ree AH; Gravdehaug B; Røsjø H; Steine K; Bratland Å; Hoffmann P; Geisler J; Omland T
    Tidsskr Nor Laegeforen; 2013 Sep; 133(17):1832-6. PubMed ID: 24042297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High risk of symptomatic cardiac events in childhood cancer survivors.
    van der Pal HJ; van Dalen EC; van Delden E; van Dijk IW; Kok WE; Geskus RB; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC
    J Clin Oncol; 2012 May; 30(13):1429-37. PubMed ID: 22473161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.